TP53 and ovarian carcinoma: However, because of the frequent missense mutations in the p53 DNA binding domain in ovarian cancer cell lines [66], it would be relevant to check p53 mutational status in 3AO cells to link formally the observed phenotypical effects of PVT1 upregulation with p53 induction.